NWCRC at the 17th Clinical Trials on Alzheimer's Disease
CTAD 2024 (January 22, 2025)
Hope, caution for WA patients 'first in line' for new schizophrenia drug
The Seattle Times (April 6, 2025)
Add-on Vraylar provides new option for treating major depressive disorder
Drug Discovery & Development (January 17, 2023)
Mental health and substance use disorders rose among youth during height of COVID pandemic
Yahoo News (January 13, 2023)
Naik G & Hensley S. U.K Urges Doctors Not to Give Paxil to Kids
Wall Street Journal (June 11, 2023)
Parkinson's Disease and Dementia
Parkinson Pathfinder (September 1, 2022)
Vedantam S. Against depression a sugar pill is hard to beat
Washington Post (May 7, 2002)
The Forgotten Patients
Forbes (September 13, 2010)
Friedman RA. Can the placebo treat depression? That depends
New York Times (June 25, 2022)
There's a new drug in development to help people with schizophrenia
NPR (August 11, 2022)
Can the Placebo Treat Depression
New York Times (June 6, 2022)
How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed COVID19
Science Direct (September 1, 2020)
More Fuel for the Debate on Prozac
New York Times (April 4, 2020)
Bower B. Placebos for depression attract scrutiny
Science News (October 9, 2002)
Good E. Reflections; More fuel for debate on Prozac
New York Times (April 25, 2000)
